Pancreatic enzyme capsules for pancreatitis, acute necrotizing

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 2 Mar 2026: Trial registered, NCT07441824
  2. 10 Apr 2026: Trial started, NCT07441824

The trials

NCT07441824: Pancreatic Enzyme Replacement in Acute Necrotizing Pancreatitis

State
Under way
Phase
Phase 3
People
140 planned
Started
10 Apr 2026
Primary completion
Jun 2027
Arms
Enteric coated enzyme preparation containing: Lipase 25000U, Amylase 18000U, Protease 1000U. These m
Results
None posted
  1. 2 Mar 2026: Trial registered
  2. 10 Apr 2026: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.